Table 2

Distribution of the available stains and final diagnosis within the case cohort retrieved, divided per scanner group

Aperio CS2/FL3DHISTECH MIDI IIHamamatsu NanoZoomer S60Total
No of cases (n)606060180
Histochemistry (n)
 H&E11210277291
 PAS668166213
 Trichrome667568209
 Jones686760195
 Congo red5121330
IF (n)
 IgG666860194
 IgA626961192
 IgM606060180
 C3626360185
 C1q616560186
 Kappa637260195
 Lambda637260195
IHC (n)
 PLA2R79521
 THSD7A79521
 DNAJB92169
Disease (n, %)
 MCD8 (13)8 (13)6 (10)22 (12)
 MN7 (12)9 (15)5 (8)21 (12)
 FSGS7 (12)6 (10)7 (12)20 (11)
 IgA nephropathy2 (3)6 (10)11 (18)19 (11)
 ANCA9 (15)4 (6)5 (8)18 (10)
 DN5 (8)7 (12)6 (10)18 (10)
 TIN6 (10)6 (10)5 (8)17 (9)
 MGRS7 (12)4 (6)5 (8)16 (9)
 Other9 (15)10 (16)10 (16)29 (16)
  • ANCA, antineutrophilic cytoplasmic antibody; DN, diabetic nephropathy; DNAJB9, Dnaj (hsp40) homologue, subfamily b, member 9; FSGS, focal segmental glomerulosclerosis; IF, immunofluorescence; IHC, immunohistochemistry; MCD, minimal change disease; MGRS, monoclonal gammopathy of renal significance; MN, membranous nephropathy; PAS, periodic acid–Schiff; PLA2R, phospholipase A2 receptor; THSD7A, thrombospondin type 1 containing 7A domain; TIN, tubulointerstitial nephritis;